ESSA Pharma to Present at Oppenheimer Annual Healthcare Conference

Rhea-AI Summary

ESSA Pharma Inc. (NASDAQ: EPIX) will present at the virtual Oppenheimer 32nd Annual Healthcare Conference on March 17, 2022, at 2:40 p.m. ET. David R. Parkinson, President and CEO, alongside COO Peter Virsik and CFO David S. Wood, will engage in one-on-one meetings during the event. ESSA focuses on developing innovative therapies for prostate cancer. A webcast of the presentation will be available on the company's website and archived for 90 days following the event.

South San Francisco, California and Vancouver, Canada, March 10, 2022 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the virtual Oppenheimer 32^nd Annual Healthcare Conference on Thursday, March 17, 2022 at 2:40 p.m. Eastern Time.

David. R. Parkinson, President and Chief Executive Officer of ESSA Pharma, will participate in and host one-on-one meetings. Peter Virsik, ESSA's Chief Operating Officer, and David S. Wood, ESSA's Chief Financial Officer, will also be participating in the one-on-one meetings.

Presentation Details

Presentation Date:               Thursday, March 17, 2022
Presentation Time:               2:40 p.m. ET

About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma.

A webcast of the presentation can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the presentation, the webcast will be archived for 90 days.

View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-oppenheimer-annual-healthcare-conference-301499623.html

SOURCE ESSA Pharma Inc

FAQ

When is ESSA Pharma's presentation at the Oppenheimer Conference?

ESSA Pharma's presentation is scheduled for March 17, 2022, at 2:40 p.m. ET.

Who will represent ESSA Pharma at the Oppenheimer Conference?

David R. Parkinson, Peter Virsik, and David S. Wood will represent ESSA Pharma.

What is the focus of ESSA Pharma?

ESSA Pharma focuses on developing novel therapies for prostate cancer.

Will there be a webcast of the presentation?

Yes, a webcast of the presentation will be available on ESSA's website and archived for 90 days.

What is the stock symbol for ESSA Pharma?

The stock symbol for ESSA Pharma is EPIX.